Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: The FUTURE survey

Archives of Cardiovascular Diseases

Volumn 105, Issue 6-7, 2012, Pages 355-365

  Cohen Solal, Alain ^a,b,c   Leurs, Irina ^d   Assyag, Patrick ^e   Beauvais, Florence ^c   Clerson, Pierre ^f   Contre, Christine ^d   Thebaut, Jean François ^g   Genoun, Maxime ^h  

^a APHP   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d Laboratoire Menarini   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f Service d'Orgamétrie Biostatistiques   (France)

^g Centre Alfred Kastler   (France)

^h Cabinet de Cardiologie   (France)

Author keywords

ACE inhibitors; Beta blockers; Ejection fraction; Epidemiology; Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPLERENONE; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL; NEBIVOLOL; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE; TRANDOLAPRIL; VALSARTAN;

AGED; CARDIAC PATIENT; CARDIOLOGIST; CONSULTATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVIEW;

EID: 84864138889     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2012.04.003     Document Type: Article

References (17)

1. R.J. Rodeheffer The new epidemiology of heart failure Curr Cardiol Rep 5 2003 181 186 (Pubitemid 38906872)
2. J.B. Bouhour Heart failure. Epidemiology - future prospects Bull Acad Natl Med 186 2002 19 29 [discussion 29-30]
3. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
4. F.A. Masoudi, E.P. Havranek, and P. Wolfe Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure Am Heart J 146 2003 250 257 (Pubitemid 36951768)
5. A. Cohen-Solal, M. Desnos, and F. Delahaye A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society Eur Heart J 21 2000 763 769
6. Logeart D, De Groote P, Dujardin JJ, et al. Clinical characteristics and in-hospital mortality of acute heart failure: the OFICA study. ESC Congress 2010; Abstract 3564: available at: http://spo.escardio.org/AbstractDetails.aspx? id=91987&eevtid=40.
7. J.B. Somaratne, C. Berry, and J.J. McMurray The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail 11 2009 855 862
8. A. Cohen-Solal Management of heart failure by general practitioners in France. Results of the study IMPROVEMENT of heart failure (IMPROVEMENT-HF) Arch Mal Coeur Vaiss 95 2002 11 15 [Spec 4] (Pubitemid 34208481)
9. P. de Groote, R. Isnard, and P. Assyag Is the gap between guidelines and clinical practice in heart failure treatment being filled. Insights from the IMPACT-RECO survey Eur J Heart Fail 9 2007 1205 1211 (Pubitemid 350153640)
10. P. de Groote, R. Isnard, and P. Clerson Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme Eur J Heart Fail 11 2009 85 91
11. G. Jullien, J.Y. Fraboulet, and P. Poncelet Registry of cardiac insufficiency in cardiology Arch Mal Coeur Vaiss 94 2001 1351 1356
12. S.M. Dunlay, M. Gheorghiade, and K.J. Reid Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial Eur J Heart Fail 12 2010 367 374
13. D.J. Holland, D.J. Kumbhani, and S.H. Ahmed Effects of treatment on exercise tolerance, cardiac function, and mortality in heart failure with preserved ejection fraction. A meta-analysis J Am Coll Cardiol 57 2011 1676 1686
14. B.M. Massie, P.E. Carson, and J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
15. G.W. Yip, M. Wang, and T. Wang The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction Heart 94 2008 573 580 (Pubitemid 351580128)
16. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781 (Pubitemid 37093918)
17. A.F. Hernandez, B.G. Hammill, and C.M. O'Connor Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) registry J Am Coll Cardiol 53 2009 184 192